Federal Supply Schedule 36F79724D048E
Award Date
7/18/24
Last Date to Order
1/14/25
Federal Agency
Veterans Integrated Service Network 12
Awardee
GC Biopharma Usa, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
GC Biopharma USA, Inc. has been awarded a Federal Supply Schedule (FSS) contract under Schedule 65 IB for drugs, pharmaceuticals, and hematology-related products. The contract was awarded by the Veterans Integrated Service Network 12, a civilian agency within the Department of Veterans Affairs. The FSS contract has a ceiling value of $25,000 and a period of performance ending on July 4, 2024. This multiple-award vehicle allows various federal agencies to efficiently procure the company's...
The federal contract IDV awarded to GC Biopharma USA, Inc. is a Federal Supply Schedule (FSS) contract under Schedule 65 IB for drugs, pharmaceuticals, and hematology-related products. The contract has a ceiling value of $23,840,000 and was awarded by the Veterans Integrated Service Network 12, a civilian agency within the Department of Veterans Affairs. The contract allows various federal agencies to efficiently procure pharmaceutical and hematology products from GC Biopharma USA, Inc....
This is a Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs (VA) to Apnar Pharma, LP, a minority-owned small disadvantaged business. The contract, with a ceiling value of $2,225,000.00, is for the provision of pharmaceutical and hematology-related products under FSS Schedule 65 IB. The contract has a period of performance from June 15, 2021 to June 14, 2026. As an FSS contract, it allows for the placement of task orders by federal agencies for the...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a Federal Supply Schedule (FSS) contract to Genericus, Inc. under the Pharmaceuticals and Drugs (FSS-61-IB) FSS master schedule. The contract, valued at up to $225,000.00, enables the procurement of drugs, pharmaceuticals, and hematology-related products. As an FSS contract, this is a multiple award vehicle that allows for indefinite delivery of the specified products and services...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the U.S. Department of Veterans Affairs. The contract, valued at a ceiling of $300,000.00, was awarded to Yaral Pharma Inc., a for-profit manufacturer, for a period of performance ending on April 30, 2028. The contract falls under Schedule 65 I B, "DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS", and is intended to provide the agency...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs (VA) to Alnylam Pharmaceuticals, Inc. The contract is for the procurement of drugs, pharmaceuticals, and hematology-related products under FSS-61-IB. The contract has a ceiling value of $4,149,600.00 and a period of performance through March 1, 2026. As a Federal Supply Schedule contract, this is a multiple award vehicle that allows for orders to be placed by VA facilities and other federal agencies against...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12, a civilian agency of the U.S. government, to Genericus, Inc. The contract is for the delivery of drugs, pharmaceuticals, and hematology-related products under Schedule 65 I B. This is a multiple award contract with a ceiling value of $850,000.00 and a period of performance ending on December 14, 2029. As a Federal Supply Schedule contract, it allows for the procurement of the specified products and...
This is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Bioxcel Therapeutics, Inc. The contract has a ceiling value of $25,000.00 and a period of performance through February 14, 2023. The contract is for an "Interim Agreement under FSS Schedule 65 I B Drugs, Pharmaceuticals, & Hematology Related Products." This indicates the contract provides for the delivery of pharmaceutical and related...
The Federal Supply Schedule (FSS) contract award with ID 36F79723D0101 was issued by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government. The contract has a maximum value of $500,000.00 and a period of performance from April 1, 2023 to March 31, 2028. The contract is for the procurement of drugs, pharmaceuticals, and hematology-related products under the FSS contract category 65 I B. The prime contractor awarded this multiple-award contract is...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency under the U.S. Department of Veterans Affairs, to Luye Pharma USA LTD, a foreign-owned for-profit organization. The $25,000 contract is for an interim agreement under FSS Schedule 65 I B for drugs, pharmaceuticals, and hematology-related products. The period of performance runs from the award date of April 3, 2025 through September 30, 2025. No set-asides were used, and...